FDA Import Refusal 1FX-6318578-9/10002/1 — ASUDHARSHAN BHAT
The FDA refused shipment 1FX-6318578-9/10002/1 from ASUDHARSHAN BHAT (India) on Jul 23, 2026. The refused product falls under Drugs and Biologics — ANTI-INFLAMMATORY N.E.C.. Cited charge: 75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Jul 23, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GCY99 ANTI-INFLAMMATORY N.E.C.
- Charges
- 75